TSHA Earnings

Quarterly EPS
$-0.10
Q3 2024
$-0.07
Q4 2024
$-0.08
Q1 2025
$-0.09
Q2 2025
$-0.09
Q3 2025
$-0.08
Q4 2025
$-0.12
Q1 2026
$-0.13
Q2 2026
Latest RevenueN/A
Latest Net Income-46639000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.130-46639000-100.0%-44.4%
Q1 2026-$0.120-42410000-100.0%-50.0%
Q4 2025-$0.085.5M-27851000+171.3%-14.3%
Q3 2025-$0.090-32733000-100.0%+10.0%
Q2 2025-$0.092.0M-26882000+78.6%+0.0%
Q1 2025-$0.082.3M-21529000-32.5%+20.0%
Q4 2024-$0.072.0M-18785000-43.9%-130.4%
Q3 2024-$0.101.8M-25524000-62.3%+89.2%
Q2 2024-$0.091.1M-20928000
Q1 2024-$0.103.4M-24061000
Q4 2023$0.233.6M47.7M
Q3 2023-$0.934.7M-117087000
Taysha Gene Therapies (TSHA) — Earnings